{"id":"CHEMBL100014","canonicalSmiles":"CCCC(=O)OCOC(=O)C(C)(C)C","inchiKey":"GYKLFBYWXZYSOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AN-9","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["An-9","Butyric Acid 2,2-Dimethyl-Propionyloxymethyl Ester","Butyric Acid 2,2-Dimethyl-Propionyloxymethyl Ester(An9)","Pivanex"],"crossReferences":{"drugbank":["DB05103"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL10188","canonicalSmiles":"CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1","inchiKey":"BIAVGWDGIJKWRM-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALNETANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-2234","SB-223412","Sb-223412","Talnetant"],"childChemblIds":["CHEMBL2146089"],"count":2,"linkedTargets":{"rows":["ENSG00000169836"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1037","canonicalSmiles":"N=C(N)NCC1COC2(CCCCC2)O1","inchiKey":"HPBNRIOWIXYZFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANADREL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Guanadrel","Hylorel"],"crossReferences":{"Wikipedia":["Guanadrel"],"drugbank":["DB00226"],"chEBI":["5555"]},"childChemblIds":["CHEMBL3184143"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1051","canonicalSmiles":"CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1","inchiKey":"GGXICVAJURFBLW-CEYXHVGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATANOPROST","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Latanoprost","Monopost","Xalatan","Xelpros"],"synonyms":["Latanoprost","PHXA-41","PHXA41","T-2345","T2345","XA-41","XA41"],"crossReferences":{"DailyMed":["latanoprost"],"PubChem":["26719861"],"Wikipedia":["Latanoprost"],"drugbank":["DB00654"],"chEBI":["6384"]},"count":5,"approvedIndications":["EFO_0004190","EFO_1001069","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["EFO_0006862","EFO_0004190","EFO_1001069","EFO_0004192","EFO_1000906","EFO_0003770","EFO_0004208","EFO_0000516"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1088750","canonicalSmiles":"CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)NCCN(C)C)cc21","inchiKey":"IFGWYHGYNVGVRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARRY-797","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-371797","ARRY-797","Arry-797"],"count":5,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0010072","EFO_0003898","EFO_0004616","EFO_0000407"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1091434","canonicalSmiles":"N[11C](=O)c1cnccn1","inchiKey":"IPEHBUMCGVEMRF-SFIIULIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Pyrazine-2-Carboxamide","maximumClinicalTrialPhase":0,"parentId":"CHEMBL614","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrazine-2-Carboxamide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160563","canonicalSmiles":"O=C(O)[C@H](O)COP(=O)(O)O","inchiKey":"OSJPPGNTCRNQQC-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-PHOSPHOGLYCERIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Phosphoglycerate"],"crossReferences":{"Wikipedia":["3-Phosphoglyceric_acid"],"drugbank":["DB04510"],"chEBI":["17794"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1165342","canonicalSmiles":"CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32","inchiKey":"RXPRRQLKFXBCSJ-GIVPXCGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINCAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Hematological toxicity"],"year":1987},"tradeNames":[],"synonyms":["Vincamine"],"crossReferences":{"PubChem":["144204895","144212285","170466430","56463369"],"drugbank":["DB13374"],"chEBI":["9985"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease. It was withdrawn in Germany  in 1987 due to Hematological toxicity."}
{"id":"CHEMBL1200326","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1.Cl","inchiKey":"AIKVCUNQWYTVTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICARDIPINE HYDROCHLORIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1484","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardene","Cardene sr","Nicardipine hydrochloride"],"synonyms":["Nicardipine hydrochloride","RS-69216","RS-69216-XX-07-0","RS-69216XX07-0","YC-93"],"crossReferences":{"DailyMed":["nicardipine%20hydrochloride"],"PubChem":["144212149","26747578","26747579","50106640","50106641","50106642"]},"count":4,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0005669","EFO_0000319","EFO_1000994","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for hypertension and has 3 investigational indications."}
{"id":"CHEMBL1200383","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2.CS(=O)(=O)O","inchiKey":"CPFJLLXFNPCTDW-BWSPSPBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZTROPINE MESYLATE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201203","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benztropine mesylate","Cogentin"],"synonyms":["Benzatropine mesilate","Benztropine mesilate","Benztropine mesylate","Benztropine methanesulfonate","NSC-169913"],"crossReferences":{"DailyMed":["benztropine%20mesylate"],"PubChem":["144203579"],"chEBI":["3049"]},"count":3,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["EFO_0002508","EFO_0009387","HP_0003418","HP_0000713"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for parkinson's disease and has 2 investigational indications."}
{"id":"CHEMBL1200426","canonicalSmiles":"CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1.Cl.O","inchiKey":"RAOHHYUBMJLHNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIXENE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metixen","Tremaril","Tremarit","Tremonil","Trest"],"synonyms":["Methixene hydrochloride","Metixene hydrochloride","SJ 1977","SJ-1977"],"crossReferences":{"PubChem":["56463218"],"chEBI":["51025"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200493","canonicalSmiles":"CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12.Cl","inchiKey":"OLUNPKFOFGZHRT-YGCVIUNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFTIFINE HYDROCHLORIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL626","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exoderil","Naftifine hydrochloride","Naftin"],"synonyms":["AW 105-843","AW-105-843","NAFT-900","NAFT900","Naftifine hydrochloride"],"crossReferences":{"DailyMed":["naftifine%20hydrochloride"],"PubChem":["144204228","170464903","56463179"],"chEBI":["7452"]},"count":1,"approvedIndications":["EFO_0007512"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and is indicated for tinea pedis."}
{"id":"CHEMBL1200662","drugType":"Small molecule","blackBoxWarning":false,"name":"HEMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hemin","NSC-122707"],"crossReferences":{"chEBI":["50385"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1200759","canonicalSmiles":"Cl.O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1","inchiKey":"TVWRQCIPWUCNMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAGRELIDE HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL760","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Agrelin","Agrylin","Anagrelide hydrochloride","Xagrid"],"synonyms":["Anagrelide hydrochloride","Anagrelide hydrochloride hydrate","Anagrelide hydrochloride monohydrate","BL-4162A","BMY-26538-01"],"crossReferences":{"DailyMed":["anagrelide%20hydrochloride"],"PubChem":["49681599"],"chEBI":["55345"]},"count":2,"approvedIndications":["HP_0004419","EFO_0000479"],"linkedTargets":{"rows":["ENSG00000152270","ENSG00000172572"],"count":2},"linkedDiseases":{"rows":["HP_0004419","EFO_0000479"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for essential thrombocythemia and recurrent thrombophlebitis."}
{"id":"CHEMBL1200878","canonicalSmiles":"CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C","inchiKey":"TZIZWYVVGLXXFV-FLRHRWPCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAMCINOLONE HEXACETONIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aristospan","Lederspan"],"synonyms":["CL 34433","CL-34433","TATBA","Triamcinolone hexacetonide"],"crossReferences":{"PubChem":["144206532"],"chEBI":["9670"]},"count":7,"approvedIndications":["HP_0006536","EFO_0002506","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000685","EFO_0002506","EFO_0009552","HP_0001742","EFO_0003843","EFO_0005752","EFO_0002609"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and has 5 approved and 2 investigational indications."}
{"id":"CHEMBL1200895","canonicalSmiles":"NNCCc1ccccc1.O=S(=O)(O)O","inchiKey":"RXBKMJIPNDOHFR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PHENELZINE SULFATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1089","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nardil","Phenelzine sulfate"],"synonyms":["NSC-170957","Phenelzine acid sulfate","Phenelzine sulfate"],"crossReferences":{"DailyMed":["phenelzine%20sulfate"],"PubChem":["11533068","144203787","144207332","170465229","26747636","26747637","49681616","50106853"],"chEBI":["8061"]},"count":2,"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0000673"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200984","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=C(O)/C=C\\C(=O)O","inchiKey":"TZNOWAJJWCGILX-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMLODIPINE MALEATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1491","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amvaz"],"synonyms":["Amlodipine maleate","UK-48,340-11","UK-48340-11"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_1002032"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003."}
{"id":"CHEMBL1201044","canonicalSmiles":"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1.Cl","inchiKey":"ZIODNPFQZIHCOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPIPRAZOLE HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201216","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dapiprazole hydrochloride","Rev-eyes"],"synonyms":["AF 2139","AF-2139","Dapiprazole hydrochloride"],"crossReferences":{"PubChem":["144206586","170466549"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1201074","canonicalSmiles":"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)CC(O)C(=O)O","inchiKey":"TZWRZMNGFHAGHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIETHYLPERAZINE MALATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1378","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Torecan"],"synonyms":[],"crossReferences":{"PubChem":["56463174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201139","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"RQZAXGRLVPAYTJ-GQFGMJRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEGESTROL ACETATE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Megace","Megace es","Megestrol acetate","Ovaban"],"synonyms":["5071","BDH 1298","BDH-1298","Megestrol","Megestrol acetate","NSC-71423","SC 10363","SC-10363"],"crossReferences":{"DailyMed":["megestrol%20acetate"],"PubChem":["144204020","144212677","170465406","26719675","56422102","856018"],"drugbank":["DB00351"]},"count":18,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005203","EFO_0003869","EFO_0006859","EFO_0005232","EFO_0003859","HP_0000726","HP_0002039","MONDO_0007254","EFO_1001512","EFO_0004230","HP_0031217","EFO_1000235","EFO_0000311","MONDO_0002691","EFO_0007312","MONDO_0041161","MONDO_0024474","HP_0004326","MONDO_0011962","MONDO_0000088","EFO_0000341","EFO_0000707"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for cancer and neoplasm and has 16 investigational indications."}
{"id":"CHEMBL1201173","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C","inchiKey":"GZENKSODFLBBHQ-ILSZZQPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDRYSONE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydroxymesterone","Medrysone","U-8471"],"crossReferences":{"PubChem":["11533031","144204077","170465194","56423131"],"Wikipedia":["Medrysone"],"drugbank":["DB00253"],"chEBI":["34829"]},"count":1,"approvedIndications":["EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005752"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969 and is indicated for eye inflammation."}
{"id":"CHEMBL1201185","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O","inchiKey":"PUDHBTGHUJUUFI-SCTWWAJVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LANREOTIDE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Somatuline autogel","Somatuline la"],"synonyms":["Lanreotide"],"crossReferences":{"DailyMed":["lanreotide%20acetate"],"Wikipedia":["Lanreotide"]},"childChemblIds":["CHEMBL1201184"],"count":20,"linkedTargets":{"rows":["ENSG00000162009","ENSG00000180616"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0000447","EFO_1001307","EFO_1001769","EFO_1001901","MONDO_0024503","HP_0002014","EFO_1001466","Orphanet_657","EFO_0004243","EFO_1001496","MONDO_0044937","MONDO_0004565","MONDO_0008315","EFO_1001471","EFO_1001485","EFO_0009431","MONDO_0002995","EFO_0000182","HP_0003074","EFO_1000852","EFO_0003769","EFO_1001095"],"count":23},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 20 investigational indications."}
{"id":"CHEMBL1201197","canonicalSmiles":"C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]21","inchiKey":"UUZPPAMZDFLUHD-VUJLHGSVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALATROFLOXACIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Hepatotoxicity"],"year":2006},"tradeNames":[],"synonyms":["Alatrofloxacin"],"crossReferences":{"Wikipedia":["Alatrofloxacin"],"drugbank":["DB09335"]},"childChemblIds":["CHEMBL1200498"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in European Union and  United States initially in 2006 due to Hepatotoxicity."}
{"id":"CHEMBL1201235","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2","inchiKey":"WKWOJBUWWZTUQV-SPUOUPEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLHOMATROPINE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["homatropine%20methylbromide"]},"childChemblIds":["CHEMBL1200851"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1943."}
{"id":"CHEMBL1201250","canonicalSmiles":"CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O","inchiKey":"JSZILQVIPPROJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZQUINAMIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emete-con","Quantril"],"synonyms":["Benzchinamide","Benzquinamide","P-2647"],"crossReferences":{"PubChem":["170465138"],"Wikipedia":["Benzquinamide"],"drugbank":["DB00767"],"chEBI":["27662"]},"childChemblIds":["CHEMBL1200707"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1201498","drugType":"Unknown","blackBoxWarning":false,"name":"AMINO ACIDS","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aminess","Amino acids","Aminosyn","Aminosyn Ii","Aminosyn-Hbc","Aminosyn-Hf","Aminosyn-Pf","Aminosyn-Rf","Branchamin","Freamine","Freamine Hbc","Freamine Ii","Freamine Iii","Hepatamine","Hepatasol","Neopham","Nephramine","Novamine","Renamin w/o electrolytes","Travasol","Trophamine"],"synonyms":["Amino acids","Amino acids nos"],"crossReferences":{"DailyMed":["amino%20acids"]},"count":7,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1201733","canonicalSmiles":"Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl","inchiKey":"MQHIQUBXFFAOMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PAZOPANIB HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL477772","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib hydrochloride"],"crossReferences":{"DailyMed":["pazopanib%20hydrochloride"],"chEBI":["71217"]},"count":27,"approvedIndications":["EFO_0000640","EFO_0000335","EFO_0000681","EFO_0000349","EFO_1001968","EFO_0003016","EFO_0000691"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000068078","ENSG00000182866","ENSG00000102755","ENSG00000077782","ENSG00000037280","ENSG00000157404","ENSG00000113721","ENSG00000182578","ENSG00000113263"],"count":11},"linkedDiseases":{"rows":["EFO_0000292","MONDO_0004192","EFO_0000681","EFO_1001465","MONDO_0007254","MONDO_0002087","MONDO_0020654","MONDO_0001187","MONDO_0002158","EFO_0000588","EFO_0003968","EFO_0000389","MONDO_0008903","EFO_1000315","EFO_0000501","EFO_0000641","MONDO_0015277","EFO_0002914","EFO_0000616","MONDO_0008170","EFO_0000349","EFO_1000314","EFO_1001968","MONDO_0008315","EFO_0001663","EFO_0000640","EFO_0006861","EFO_0000335","EFO_1000613","EFO_0000691","EFO_0003016"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 7 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201787","canonicalSmiles":"CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1.[Cl-]","inchiKey":"HPKFFZSXDWPVLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAPYRIUM CHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201786","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lapirium chloride","Lapyrium chloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201833","drugType":"Antibody","blackBoxWarning":true,"name":"GOLIMUMAB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Simponi"],"synonyms":["CNTO 148","CNTO-148","Golimumab"],"crossReferences":{"DailyMed":["golimumab"],"DrugCentral":["4967"],"Wikipedia":["Golimumab"]},"count":12,"approvedIndications":["EFO_0000729","EFO_0000685","EFO_0003898","EFO_0003778","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["Orphanet_797","EFO_0000729","EFO_0000685","EFO_0009672","EFO_0003898","EFO_0003778","EFO_0000540","EFO_0002609","MONDO_0019474","EFO_0002506","EFO_0000270","EFO_0001359","EFO_0000706","EFO_0003872"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 5 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1206245","canonicalSmiles":"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(OP(=O)(O)O)c2)c(OC)c1","inchiKey":"LXENKEWVEVKKGV-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRICICLIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Briciclib","ON 014185","ON-014185","On-013105"],"crossReferences":{"drugbank":["DB12004"]},"childChemblIds":["CHEMBL3137303","CHEMBL1627071"],"count":1,"linkedTargets":{"rows":["ENSG00000110092"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000220"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1213251","canonicalSmiles":"CC(Cc1ccccc1)NCc1ccccc1Cl","inchiKey":"LRXXRIXDSAEIOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOBENZOREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clobenzorex","SD 271-12"],"crossReferences":{"PubChem":["29216105"],"Wikipedia":["Clobenzorex"]},"childChemblIds":["CHEMBL2360490"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1214827","canonicalSmiles":"CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O","inchiKey":"IFRGXKKQHBVPCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONALESPIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-13387X","ATI13387X","Onalespib"],"crossReferences":{"drugbank":["DB06306"]},"childChemblIds":["CHEMBL3301599"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL12208","canonicalSmiles":"Cc1cc(=O)oc2cc(O)ccc12","inchiKey":"HSHNITRMYYLLCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYMECROMONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cantabiline"],"synonyms":["Hymecromone","LM-94","NSC-19026","NSC-9408"],"crossReferences":{"PubChem":["11112236","144203936","144211232","170465819","174006226","47193740","74901"],"Wikipedia":["Hymecromone"],"drugbank":["DB07118"],"chEBI":["17224"]},"childChemblIds":["CHEMBL3184017"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1230438","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"RAJWOBJTTGJROA-WZNAKSSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230438","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01561"],"chEBI":["15994"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230742","canonicalSmiles":"COc1cc(-c2ccc(OC)nc2)c2oc(NS(=O)(=O)c3cc(Cl)ccc3Cl)nc2c1","inchiKey":"KOKQLKWXOFRTHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230742","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07321"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231778","canonicalSmiles":"N[C@H](CO)CC1CCCCC1","inchiKey":"QWDRYURVUDZKSG-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231778","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04387"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233457","canonicalSmiles":"CCCCCCCCC[C@@H](O)CC(=O)O","inchiKey":"MUCMKTPAZLSKTL-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxylauric Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxylauric Acid"],"crossReferences":{"drugbank":["DB07930"],"chEBI":["43197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235252","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"BHMBVRSPMRCCGG-OUTUXVNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROSTAGLANDIN D2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26754808"],"drugbank":["DB02056"],"chEBI":["15555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235693","canonicalSmiles":"COc1cc(NC(=N)NC(=N)N)cc(OC)c1","inchiKey":"VQKIGKHIRBCYNE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235693","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24795891"],"drugbank":["DB08479"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236251","canonicalSmiles":"CCOP(=O)(OCC)OCC","inchiKey":"DQWPFSLDHJDLRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIETHYL PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209661","144213423","17388682","56462770"],"drugbank":["DB03347"],"chEBI":["45927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236684","canonicalSmiles":"CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"FEPMHVLSLDOMQC-IYPFLVAKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VIRGINIAMYCIN FACTOR S","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E711","Virginiamycin factor s"],"crossReferences":{"drugbank":["DB04805"],"chEBI":["46416"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256772","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC.Cl","inchiKey":"OTFDPNXIVHBTKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAPRIDE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL84158","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiapridal","Tiapride hydrochloride"],"crossReferences":{"PubChem":["144203827","170465877","26747665","50107033","56422896","855786"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1316","canonicalSmiles":"CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12","inchiKey":"PUXBGTOOZJQSKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARPROFEN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rimadyl"],"synonyms":["Carprofen","RO 20-5720/000","Ro-205720000"],"crossReferences":{"PubChem":["144204916","170464799","26748565","50085988"],"Wikipedia":["Carprofen"],"drugbank":["DB00821"],"chEBI":["364453"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1332032","canonicalSmiles":"CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O","inchiKey":"RMWVZGDJPAKBDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUSAL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Triflusal"],"crossReferences":{"PubChem":["11112328","144203987"],"Wikipedia":["Triflusal"],"drugbank":["DB08814"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1334692","canonicalSmiles":"O=C(O)Cc1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1","inchiKey":"XVUQHFRQHBLHQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LONAZOLAC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lonazolac"],"crossReferences":{"PubChem":["144205365","170466434","24834413","29216121"],"drugbank":["DB13432"],"chEBI":["76164"]},"childChemblIds":["CHEMBL2172780"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1371","canonicalSmiles":"O=c1[nH]c2cc(Cl)ccc2o1","inchiKey":"TZFWDZFKRBELIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORZOXAZONE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorzoxazone","Paraflex","Parafon","Parafon Forte","Parafon forte dsc","Parafon-Forte","Strifon","Strifon forte dsc"],"synonyms":["Chlorzoxazone","NSC-26189"],"crossReferences":{"DailyMed":["chlorzoxazone"],"PubChem":["11110945","11110946","144203656","170464957","50106005","8139927","85230968","90340987"],"Wikipedia":["Chlorzoxazone"],"drugbank":["DB00356"],"chEBI":["3655"]},"linkedTargets":{"rows":["ENSG00000104783"],"count":1},"linkedDiseases":{"rows":["MONDO_0002046","EFO_1000786","EFO_0004616","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL139908","canonicalSmiles":"CCCC(=O)SCC[N+](C)(C)C","inchiKey":"AWBGQVBMGBZGLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL139908","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04250"],"chEBI":["41055"]},"childChemblIds":["CHEMBL148530"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1424","canonicalSmiles":"O=c1[nH]c(=O)c2nc[nH]c2[nH]1","inchiKey":"LRFVTYWOQMYALW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANTHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xanthine"],"crossReferences":{"PubChem":["26757757"],"Wikipedia":["Xanthine"],"drugbank":["DB02134"],"chEBI":["17712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14309","canonicalSmiles":"CCC(=O)O[C@@]1(c2ccccc2)CCN(C)C[C@H]1C","inchiKey":"UVAZQQHAVMNMHE-CJNGLKHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHAPRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Prodine"],"drugbank":["DB13160"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1472975","canonicalSmiles":"O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1","inchiKey":"FBVFZWUMDDXLLG-HDICACEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEROSPIRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perospirone"],"crossReferences":{"PubChem":["26757988"],"drugbank":["DB08922"]},"childChemblIds":["CHEMBL1713496"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15063","canonicalSmiles":"CCNc1nc(Cl)nc(NC(C)C)n1","inchiKey":"MXWJVTOOROXGIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atrazine"],"crossReferences":{"PubChem":["144209184","144211338","17390035","22407690","26752800","56314826"],"Wikipedia":["Atrazine"],"drugbank":["DB07392"],"chEBI":["15930"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1513","canonicalSmiles":"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1","inchiKey":"YOSHYTLCDANDAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IRBESARTAN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aprovel","Avapro","Ifirmasta","Irbesartan","Karvea","Sabervel"],"synonyms":["BMS-186295","Irbesartan","SR 47436","SR-47436"],"crossReferences":{"DailyMed":["irbesartan"],"PubChem":["144204986","170464670","26719813","26748950"],"Wikipedia":["Irbesartan"],"drugbank":["DB01029"],"chEBI":["5959"]},"count":14,"approvedIndications":["EFO_0000401","EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0000275","Orphanet_286","EFO_0000401","EFO_0000373","EFO_0004236","EFO_0000319","EFO_0004194","Orphanet_558","EFO_0000537","HP_0100806","MONDO_0001302","EFO_0004220","EFO_1001375","EFO_0003144","EFO_0003884","EFO_1002032","EFO_0000612","EFO_0007243","EFO_0001360","EFO_0004285","HP_0012594"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL151604","canonicalSmiles":"CC1=C(C)C(=O)C(C)=C(C)C1=O","inchiKey":"WAMKWBHYPYBEJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUROQUINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3,5,6-Tetramethyl-[1,4]Benzoquinone"],"crossReferences":{"Wikipedia":["Duroquinone"],"drugbank":["DB01927"],"chEBI":["42023"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1518","canonicalSmiles":"CCCc1cc(=O)[nH]c(=S)[nH]1","inchiKey":"KNAHARQHSZJURB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPYLTHIOURACIL","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Propacil","Propylthiouracil","Prothyran","Thyreostat"],"synonyms":["NSC-6498","NSC-70461","Propylthiouracil"],"crossReferences":{"DailyMed":["propylthiouracil"],"PubChem":["11112111","144204433","144208939","144210600","170464965","17389748","174006773","26751509","855783"],"TG-GATEs":["29"],"Wikipedia":["Propylthiouracil"],"drugbank":["DB00550"],"chEBI":["8502"]},"count":3,"approvedIndications":["HP_0000820"],"linkedTargets":{"rows":["ENSG00000211452","ENSG00000115705"],"count":2},"linkedDiseases":{"rows":["EFO_0009190","EFO_1001466","HP_0000820"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and is indicated for abnormality of the thyroid gland and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1521495","canonicalSmiles":"O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1","inchiKey":"AIZFEOPQVZBNGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENTAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bentazepam","CI-718"],"crossReferences":{"PubChem":["50085894"],"drugbank":["DB14719"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1536","canonicalSmiles":"C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C","inchiKey":"MECHNRXZTMCUDQ-RKHKHRCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGOCALCIFEROL","yearOfFirstApproval":1941,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calciferol","Calciferol in arach oil","Caltrate","D-forte","Deltalin","Drisdol","Eciferol d2","Ergo-d2","Ergocalciferol","Ergoral d2","Lanes","Oleovitamin D","Osto-d2","Sterogyl","Sterogyl 15h","Sterogyl-15","Uvesterol d","Vitamin D 2","Vitamin d"],"synonyms":["Calciferol","Ergocalciferol","NSC-62792","Oleovitamin d, synthetic","Viosterol in oil","Vitamin d2"],"crossReferences":{"DailyMed":["ergocalciferol"],"PubChem":["144205957","144209546","144213069","57264355"],"Wikipedia":["Ergocalciferol"],"drugbank":["DB00153"],"chEBI":["28934"]},"count":70,"approvedIndications":["Orphanet_437","HP_0002148","EFO_0009451"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003869","EFO_1001173","Orphanet_437","HP_0000989","EFO_0003095","EFO_0000249","EFO_0004278","EFO_0003762","EFO_0000266","EFO_0005952","EFO_1001951","EFO_0003964","EFO_0000565","EFO_1000653","HP_0000938","EFO_0004593","EFO_0003931","EFO_0002506","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_0003884","EFO_0008528","EFO_0007319","EFO_0000676","EFO_0004616","EFO_0000400","EFO_0004288","EFO_0003888","HP_0002148","HP_0005521","EFO_0003821","EFO_0005583","Orphanet_3389","EFO_0009516","EFO_1002029","EFO_0000384","MONDO_0008315","EFO_0000660","Orphanet_309005","EFO_0004192","MONDO_0100096","EFO_0008519","EFO_1000049","EFO_0000270","EFO_0001359","EFO_0000574","EFO_0001360","EFO_0003767","EFO_0003922","EFO_0005672","EFO_1001792","EFO_0007405","EFO_1001494","Orphanet_232","EFO_0005878","MONDO_0007254","Orphanet_586","EFO_0000373","EFO_0009451","EFO_0000274","EFO_0003882","EFO_0002950","EFO_1001480","EFO_0004247","EFO_1001375","EFO_0003144","Orphanet_89936","EFO_0000673","EFO_0003837","EFO_0003047","EFO_0003917","EFO_0009706","EFO_0000685","EFO_0000186","EFO_0004261","EFO_0000545","EFO_0008572","HP_0002024","Orphanet_666","EFO_0001073","EFO_0003843","EFO_0000311","MONDO_0002171","EFO_0003885","EFO_0003834","EFO_0004220","HP_0003549","EFO_0002614","EFO_0003854","EFO_0000764","MONDO_0011962","EFO_1001890","Orphanet_355","EFO_0009314","EFO_0004270","MONDO_0024880","EFO_0007176"],"count":99},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1941 and has 3 approved and 67 investigational indications."}
{"id":"CHEMBL1546237","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)[O-])cc4CC[C@H]3[C@@H]1CCC2=O.[K+]","inchiKey":"CUQHOFAEIPGLBH-ZFINNJDLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1546237","maximumClinicalTrialPhase":0,"parentId":"CHEMBL494753","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["855881"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1563050","canonicalSmiles":"Cc1cc(C)nc([N-]S(=O)(=O)c2ccc(N)cc2)n1.[Na+]","inchiKey":"NGIVTUVVBWOTNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1563050","maximumClinicalTrialPhase":0,"parentId":"CHEMBL446","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112954","56463538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1569545","canonicalSmiles":"O=C(O)Cn1c2ccccc2c(=O)c2ccccc21","inchiKey":"UOMKBIIXHQIERR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRIDANIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cridanimod"],"crossReferences":{"PubChem":["144205901","170466071","29217965","50086600","56422767"],"drugbank":["DB13674"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1570","canonicalSmiles":"O=S(O)CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)O)cc2)cc1","inchiKey":"NEDPPCHNEOMTJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFOXONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Sulfoxone"],"crossReferences":{"Wikipedia":["Sulfoxone"],"drugbank":["DB01145"]},"childChemblIds":["CHEMBL1200580"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1572","canonicalSmiles":"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O","inchiKey":"CIDUJQMULVCIBT-MQDUPKMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETILMICIN","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Netilmicin"],"crossReferences":{"Wikipedia":["Netilmicin"],"drugbank":["DB00955"]},"childChemblIds":["CHEMBL3989829"],"count":3,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for eye infection and bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1601","canonicalSmiles":"O=C(O)C1=C(CSc2nnnn2CS(=O)(=O)O)CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12","inchiKey":"DYAIAHUQIPBDIP-AXAPSJFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFONICID","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefonicid"],"crossReferences":{"PubChem":["50112712"],"Wikipedia":["Cefonicid"],"drugbank":["DB01328"],"chEBI":["3491"]},"childChemblIds":["CHEMBL1201005","CHEMBL2105997"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1614854","canonicalSmiles":"OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"WQZGKKKJIJFFOK-VFUOTHLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02379"],"chEBI":["15903"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1615438","canonicalSmiles":"C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1","inchiKey":"ZCGOMHNNNFPNMX-KYTRFIICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOCABASTINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Livostin direct"],"synonyms":["Levocabastine","R-50547"],"crossReferences":{"drugbank":["DB01106"]},"childChemblIds":["CHEMBL1237102"],"count":4,"approvedIndications":["EFO_0005751","HP_0001742"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005751","EFO_1001417","HP_0001742","EFO_0003956"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for eye allergy and nasal obstruction and has 2 investigational indications."}
{"id":"CHEMBL1615487","canonicalSmiles":"O=C(CCOCCOCCOCCOCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I","inchiKey":"WWVAPFRKZMUPHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOXAMIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Endobil","Endomirabil","Videocolangio"],"synonyms":["B 10610","Iodoxamic acid","SQ 21982"],"crossReferences":{"PubChem":["170465432"],"drugbank":["DB13539"]},"childChemblIds":["CHEMBL4594231"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1650595","canonicalSmiles":"NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1","inchiKey":"YULUCECVQOCQFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-12","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-12","Ar-12","OSU-03012"],"crossReferences":{"PubChem":["172131582"]},"count":1,"linkedTargets":{"rows":["ENSG00000140992"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL168083","canonicalSmiles":"Cc1ccc(C(=O)N(c2cc(-c3ccccc3)sc2C(=O)O)C(C)C)cc1","inchiKey":"LRHXIDOGMBZJFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL168083","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03647"],"chEBI":["43541"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697686","canonicalSmiles":"CCOC(=O)NC(C)(C)Cc1ccc(Cl)cc1","inchiKey":"TZWKUQDQKPYNLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFOREX","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Cardiotoxicity"],"year":1969},"tradeNames":[],"synonyms":["Cloforex","D 237"],"crossReferences":{"PubChem":["144206822"],"Wikipedia":["Cloforex"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1969 due to Cardiotoxicity."}
{"id":"CHEMBL170077","canonicalSmiles":"N#Cc1ccc(N/C(=N\\CC(=O)O)NC(c2ccccc2)c2ccccc2)cc1","inchiKey":"KGHMYJFHUHFOGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL170077","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07816"],"chEBI":["385425"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1706","canonicalSmiles":"Cl.c1ccc2c(CC3=NCCN3)cccc2c1","inchiKey":"DJDFFEBSKJCGHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPHAZOLINE HYDROCHLORIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL761","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albalon","Antistin-privine","Gppe nsl soln","Nafazair","Naphaz hcl","Naphazoline hydrochloride","Naphcon","Naphcon forte","Opcon","Vasocon"],"synonyms":["NSC-35711","Naphazoline HCl","Naphazoline hydrochloride","Naphazoline nitrate"],"crossReferences":{"DailyMed":["naphazoline%20hydrochloride"],"PubChem":["56422379","855777"],"chEBI":["7470"]},"count":4,"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MP_0001845","EFO_0000678","EFO_0007328","EFO_0007141","EFO_0007214"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 4 investigational indications."}
{"id":"CHEMBL1722501","canonicalSmiles":"CCC1(CC)C(=O)C=CNC1=O","inchiKey":"NZASCBIBXNPDMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHYLDIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrithyldione"],"crossReferences":{"PubChem":["104171286","11112204","144203919","170466442","56463049"],"drugbank":["DB13331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1723241","canonicalSmiles":"CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.O.[Na+]","inchiKey":"IHCDKJZZFOUARO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACETAMIDE SODIUM","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL455","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albucid","Bleph","Bleph-10","Bleph-30","Cetamide","Isopto cetamide","Klaron","Novacet","Ocusol","Ocusulf","Ocusulf-10","Ocusulf-30","Sodium sulamyd","Sodium sulfacetamide","Sulf-10","Sulf-15","Sulfacel","Sulfacel-15","Sulfacetamide sodium","Sulfair 10","Sulfair forte","Sulfair-15","Sulten-10"],"synonyms":["NSC-625324","Sulfacetamide sodium","Sulfacetamide sodium salt","Sulfacetamide sodium salt monohydrate"],"crossReferences":{"DailyMed":["sulfacetamide%20sodium"],"PubChem":["11112977","56463335"],"chEBI":["63858"]},"count":2,"approvedIndications":["MP_0001845","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for inflammation and acne."}
{"id":"CHEMBL1738962","canonicalSmiles":"Cn1sc(Cl)cc1=O","inchiKey":"DHNRXBZYEKSXIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1738962","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206242","144210519"],"drugbank":["DB14197"],"chEBI":["53621"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743076","drugType":"Antibody","blackBoxWarning":false,"name":"TADOCIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C4G1","Tadocizumab","YM-337","YM337"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1773943","canonicalSmiles":"O=C(O)c1c[nH]cn1","inchiKey":"NKWCGTOZTHZDHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-IMIDAZOLECARBOXYLIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-imidazolecarboxylic acid"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1788385","canonicalSmiles":"Cc1cc(Br)c(O)c2ncccc12","inchiKey":"JMOVFFLYGIQXMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILBROQUINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tilbroquinol"],"crossReferences":{"Wikipedia":["Tilbroquinol"],"drugbank":["DB13222"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1875999","canonicalSmiles":"C[C@]12CCC3C(C(=O)C=C4C[C@@H](O)CC[C@@]43C)C1CCC2=O","inchiKey":"KPRGOTLNGIBVFL-VYLIMTTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-KETO DEHYDROEPIANDROSTERONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-keto dehydroepiandrosterone"],"crossReferences":{"PubChem":["85305127"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL188343","canonicalSmiles":"c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1","inchiKey":"ZFLJHSQHILSNCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVERSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Reversine"],"crossReferences":{"PubChem":["174007245","29217638"],"drugbank":["DB07340"],"chEBI":["70723"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189475","canonicalSmiles":"C[C@@H](C(=O)NS(C)(=O)=O)c1ccc(OS(=O)(=O)C(F)(F)F)cc1","inchiKey":"DDLPYOCJHQSVSZ-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LADARIXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Df2156a","Ladarixin"],"childChemblIds":["CHEMBL4442431"],"count":2,"linkedTargets":{"rows":["ENSG00000180871","ENSG00000163464"],"count":2},"linkedDiseases":{"rows":["EFO_0001359","EFO_0007187"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1905073","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2cnc3c(Cl)cccc3n2)cc1","inchiKey":"CTSNHMQGVWXIEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORSULFAQUINOXALINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chloroquinoxaline sulfonamide","Chlorsulfaquinoxaline","NSC-339004"],"crossReferences":{"PubChem":["461007","92763856"],"drugbank":["DB12921"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1909283","canonicalSmiles":"CC(NN)c1ccccc1","inchiKey":"HHRZAEJMHSGZNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBANAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1975},"tradeNames":[],"synonyms":["Mebanazine"],"crossReferences":{"Wikipedia":["Mebanazine"],"drugbank":["DB09248"]},"childChemblIds":["CHEMBL3186515"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1975 due to Hepatotoxicity."}
{"id":"CHEMBL1983350","canonicalSmiles":"CC(C)(C)C(O)/C=C/c1ccc2c(c1)OCO2","inchiKey":"IBLNKMRFIPWSOY-FNORWQNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STIRIPENTOL","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diacomit"],"synonyms":["BCX 2600","BCX-2600","Stiripentol"],"crossReferences":{"DailyMed":["stiripentol"],"PubChem":["124896656","144207171"],"drugbank":["DB09118"]},"count":3,"approvedIndications":["EFO_0000474","Orphanet_33069"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for epilepsy and dravet syndrome and has 1 investigational indication."}
{"id":"CHEMBL2022411","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1","inchiKey":"NGTVDHYUFBKWID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Alpha-Methylfentanyl","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Methylfentanyl"],"crossReferences":{"drugbank":["DB01557"]},"childChemblIds":["CHEMBL3188385"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2037511","canonicalSmiles":"CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C","inchiKey":"UWHCWRQFNKUYCG-QUZACWSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPELSIBAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epelsiban","GSK-557296","GSK557296","GSK557296B","Gsk557296"],"crossReferences":{"drugbank":["DB11934"]},"childChemblIds":["CHEMBL2105736"],"count":1,"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_1001757"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103758","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O","inchiKey":"TZIRZGBAFTZREM-MKAGXXMWSA-N","drugType":"Protein","blackBoxWarning":true,"name":"PRAMLINTIDE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AC-0137","AC-137","AC0137","AC137","Pramlintide","Tripro-amylin"],"crossReferences":{"drugbank":["DB01278"]},"childChemblIds":["CHEMBL3833353"],"count":4,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0004566","EFO_0001359","HP_0001943","EFO_0001360","EFO_0001073","EFO_1001927","EFO_0000400"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for diabetes mellitus and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104588","canonicalSmiles":"COP(=S)(OC)Oc1ccc(S(N)(=O)=O)cc1","inchiKey":"BSBSDQUZDZXGFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTHIOATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cythioate"],"crossReferences":{"PubChem":["144206631"],"drugbank":["DB11392"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104608","canonicalSmiles":"CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1ccc(F)c(Oc2ccccc2)c1","inchiKey":"QQODLKZGRKWIFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYFLUTHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY VL 1704","Cyfluthrin"],"crossReferences":{"PubChem":["144210962"],"drugbank":["DB13828"],"chEBI":["4034"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104964","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.Clc1ccc(OC[C@H]2CCN2)cn1","inchiKey":"JCPWIGCGJUGLJQ-OGFXRTJISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEBANICLINE TOSYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL430497","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-165594","A-166594.47","ABT-165594","ABT-594","Ebanicline tosylate","Tebanicline tosylate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105240","canonicalSmiles":"CC(=O)Oc1cc(C)cc2c1C1=C(CCC(C)C1)C(C)(C)O2","inchiKey":"AADNQNOXNWEYHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRNABINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirnabin","Pirnabine","SP-304"],"crossReferences":{"drugbank":["DB12840"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105669","canonicalSmiles":"Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](COP(=O)(O)O)OC4=O)cc3F)cn2)n1","inchiKey":"QCGUSIANLFXSGE-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDIZOLID PHOSPHATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sivextro"],"synonyms":["TR-701 FA","TR-701-FA","TR-701FA","Tedizolid phosphate","Torezolid phosphate"],"crossReferences":{"DailyMed":["tedizolid%20phosphate"],"drugbank":["DB09042"],"chEBI":["83326"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 7 investigational indications."}
{"id":"CHEMBL2105709","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1.Cl.Cl","inchiKey":"DHYPGRVMIOATAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUIZARTINIB DIHYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL576982","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-010220 DIHYDROCHLORIDE","AC-220 DIHYDROCHLORIDE","AC010220 2HCL","AC010220.2HCL","AC220","AC220 2HCL","Quizartinib dihydrochloride"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105841","canonicalSmiles":"COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3.[Cl-].[Cl-]","inchiKey":"IRPSJVWFSWAZSZ-OIUSMDOTSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLTUBOCURARINIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1259","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethyltubocurarine","Dimethyltubocurarinium chloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106049","canonicalSmiles":"[C]","inchiKey":"OKTJSMMVPCPJKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHARCOAL, ACTIVATED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AST-120","Ast 120","Carbo vegetabilis","Carbon","Carbon, medicinal","Charcoal, activated","Medicinal carbon","Medicinal charcoal"],"crossReferences":{"drugbank":["DB09278"],"chEBI":["27594"]},"count":14,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2106076","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1csc(N)n1.O=S(=O)(O)O","inchiKey":"RKTNPKZEPLCLSF-QHBKFCFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPIROME SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL65794","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefrom"],"synonyms":["Cefpirome sulfate","HR 810 SULFATE"],"crossReferences":{"PubChem":["144206351"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106372","canonicalSmiles":"O=C(COCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I","inchiKey":"FZDZULUFHNDEDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOGLYCAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BE 419","Ioglycamic acid"],"crossReferences":{"drugbank":["DB13741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106622","canonicalSmiles":"N[C@@H](Cc1cc([131I])c(Oc2ccc(O)c([131I])c2)c([131I])c1)C(=O)O","inchiKey":"AUYYCJSJGJYCDS-UMVFHIKJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIOTHYRONINE I 131","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1544","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tri-thyrotope","Triomet-131"],"synonyms":["Liothyronine i 131"],"crossReferences":{"drugbank":["DB12425"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106801","canonicalSmiles":"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"ZXSWTMLNIIZPET-ZOFHRBRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORMETHANDRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylestrenolone","Methylnortestosterone","Normethandrolone","Normethandrone","Normethisterone"],"crossReferences":{"drugbank":["DB13533"],"chEBI":["34896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106989","canonicalSmiles":"CC(C)[C@H]1CC[C@H](C)C[C@@H]1O","inchiKey":"NOOLISFMXDJSKH-AEJSXWLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACEMENTHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208241"],"drugbank":["DB11344"],"chEBI":["76306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107396","canonicalSmiles":"CC(C(=O)O)c1cccc2c(-c3ccccc3)coc12","inchiKey":"ODZUWQAFWMLWCF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURAPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enprofen","Furaprofen","R-803"],"crossReferences":{"drugbank":["DB06499"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107553","canonicalSmiles":"O=C1NOCC1/N=C/c1ccc(/C=N/C2CONC2=O)cc1","inchiKey":"ODKYYBOHSVLGNU-IAGONARPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERIZIDONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Terizidone"],"crossReferences":{"drugbank":["DB12954"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107779","canonicalSmiles":"C/C(=N\\NC(=N)N)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c2)cc(/C(C)=N/NC(=N)N)c1","inchiKey":"PWDYHMBTPGXCSN-VCBMUGGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNI-1493","CPSI-2364 FREE BASE","Cni-1493","Semapimod"],"crossReferences":{"drugbank":["DB12094"]},"count":1,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000384"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107801","canonicalSmiles":"COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1","inchiKey":"JQOFKKWHXGQABB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESEQUINIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-3933","Ac-3933","Radequinil","Resequinil","SX-3933"],"count":1,"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107831","canonicalSmiles":"CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\\C)C(=O)O)c(Cl)c3)n2)c1OC","inchiKey":"NOZIJMHMKORZBA-KJCUYJGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUSUTROMBOPAG","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mulpleta","S-888711"],"synonyms":["Lusutrombopag","RSC888711","S-888711"],"crossReferences":{"DailyMed":["lusutrombopag"],"drugbank":["DB13125"]},"count":3,"approvedIndications":["MP_0001914","HP_0001873"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0007160","HP_0001873"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for thrombocytopenia and hemorrhage and has 1 investigational indication."}
{"id":"CHEMBL2108055","drugType":"Antibody","blackBoxWarning":false,"name":"TEFIBAZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aurexis"],"synonyms":["INH-H2002","INHH-2002","Tefibazumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108147","drugType":"Enzyme","blackBoxWarning":false,"name":"STREPTOKINASE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kabikinase","Streptase"],"synonyms":["Streptokinase"],"count":5,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_1001375","EFO_0003827","EFO_1000652","EFO_0008583","EFO_0000612","HP_0004419","EFO_0009637","HP_0004936"],"count":9},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for recurrent thrombophlebitis and has 4 investigational indications."}
{"id":"CHEMBL2108252","drugType":"Antibody","blackBoxWarning":false,"name":"APOLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Remitogen smart1d10"],"synonyms":["Apolizumab","HU-1D10","HU1D10"],"count":5,"linkedTargets":{"rows":["ENSG00000198502","ENSG00000196126"],"count":2},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_1001469"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108268","drugType":"Unknown","blackBoxWarning":false,"name":"CELLULOSE, OXIDIZED","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxycel","Surgicel"],"synonyms":["Cellulose, absorbable","Cellulose, oxidized","Oxidised cellulose"],"description":"Unknown drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108702","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"IMETELSTAT SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GRN-163L TRIDECASODIUM SALT","GRN163L","GRN163L TRIDECASODIUM SALT","Imetelstat sodium"],"count":4,"linkedTargets":{"rows":["ENSG00000164362"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008903","MONDO_0007254","EFO_0001378"],"count":4},"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108834","drugType":"Small molecule","blackBoxWarning":false,"name":"BELLADONNA ROOT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bellad"],"synonyms":["Belladonna root"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108931","drugType":"Enzyme","blackBoxWarning":false,"name":"CRISANTASPASE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erwinase"],"synonyms":["Crisantaspase"],"count":5,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109047","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON ALFA-N3","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alferon ldo","Alferon n gel","Alferon n injection"],"synonyms":["Interferon alfa-n3","Leukocyte interferon"],"count":2,"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0000694","EFO_0000764"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 2 investigational indications."}
{"id":"CHEMBL2109321","drugType":"Antibody","blackBoxWarning":false,"name":"CAROTUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carotuximab","DE-122","TRC-105","c-SN6j"],"count":21,"linkedTargets":{"rows":["ENSG00000106991"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001365","EFO_0000681","EFO_0000349","EFO_1001465","MONDO_0007254","EFO_1001968","EFO_0002501","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0009708","EFO_0000640","EFO_0003968","MONDO_0003268","MONDO_0008903","EFO_0000182","EFO_0002499","EFO_1001111","EFO_0002893","EFO_0000519"],"count":21},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 21 investigational indications."}
{"id":"CHEMBL2109410","drugType":"Antibody","blackBoxWarning":false,"name":"TB-402","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TB-402","Tb-402"],"count":1,"linkedTargets":{"rows":["ENSG00000185010"],"count":1},"linkedDiseases":{"rows":["EFO_0004286"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109574","drugType":"Antibody","blackBoxWarning":false,"name":"ASG-5ME","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASG-5ME","Asg-5me"],"count":1,"linkedTargets":{"rows":["ENSG00000204385"],"count":1},"linkedDiseases":{"rows":["EFO_0001663"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109643","drugType":"Antibody","blackBoxWarning":false,"name":"F19 131I","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIBH-1","F19","F19 131i"],"count":1,"linkedTargets":{"rows":["ENSG00000078098"],"count":1},"linkedDiseases":{"rows":["EFO_0007175","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2110580","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](OCc2ccccc2)[C@H](C)O1","inchiKey":"FIGNGSHKNAHTSH-JJMFXPFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERUBICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berubicin"],"childChemblIds":["CHEMBL2103796"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000326","EFO_0000313"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110816","canonicalSmiles":"CC(CC1c2ccccc2CCc2ccccc21)CN(C)C","inchiKey":"ALELTFCQZDXAMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTRIPTYLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evadene","Evadyne"],"synonyms":["Butriptyline"],"crossReferences":{"PubChem":["170466439"],"drugbank":["DB09016"]},"childChemblIds":["CHEMBL2106170"],"count":1,"approvedIndications":["EFO_0003761"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL2137530","canonicalSmiles":"c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1","inchiKey":"CEGSUKYESLWKJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERDEMETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-26854165","Serdemetan"],"crossReferences":{"PubChem":["137276015"],"drugbank":["DB12027"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL214253","canonicalSmiles":"O=C1NC(=O)c2c1c(-c1ccccc1)cc1[nH]c3ccc(O)cc3c21","inchiKey":"IAUZTOZLTFSMIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-407824","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-407824"],"crossReferences":{"PubChem":["50112977"],"drugbank":["DB04608"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146093","canonicalSmiles":"C#Cc1cncc([C@@H]2CCCN2C)c1.O=C(O)/C=C/C(=O)O","inchiKey":"BCPPKHPWLRPWBJ-GYDOPSIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTINICLINE MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL111659","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Altinicline maleate","SIB-1508Y"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL215303","canonicalSmiles":"C[C@H]1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21","inchiKey":"NJDRXTDGYFKORP-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GARENOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Garenoxacin"],"crossReferences":{"PubChem":["50126319"],"drugbank":["DB06160"]},"childChemblIds":["CHEMBL3183451"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2181927","canonicalSmiles":"CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2","inchiKey":"BTBHLEZXCOBLCY-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINERENONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 94-8862","BAY-94-8862","Bay94-8862","Finerenone"],"count":2,"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000401"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL218490","canonicalSmiles":"CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21","inchiKey":"IAVUPMFITXYVAF-XPUUQOCRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORZOLAMIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dorzant","Trusopt"],"synonyms":["Dorzolamide","MK-507","Trusopt"],"crossReferences":{"DailyMed":["dorzolamide%20hydrochloride"],"Wikipedia":["Dorzolamide"],"drugbank":["DB00869"],"chEBI":["4702"]},"childChemblIds":["CHEMBL1201162"],"count":4,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000104267"],"count":1},"linkedDiseases":{"rows":["EFO_0003966","EFO_0004190","EFO_1001069","EFO_0004683","EFO_0000516"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for glaucoma and has 3 investigational indications."}
{"id":"CHEMBL2203744","canonicalSmiles":"CN(C(=S)NN=C(c1ccccn1)c1ccccn1)C1CCCCC1","inchiKey":"GNLZNQJBZNOUBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2203744","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15235"]},"childChemblIds":["CHEMBL2203739"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221170","canonicalSmiles":"COc1cccc(-c2cccc(CCc3cccc(N)n3)c2)c1","inchiKey":"AEVBKBAFFJKFJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221170","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07245"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225304","canonicalSmiles":"NN=C(N)N","inchiKey":"HAMNKKUPIHEESI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMAGEDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminoguanidine","Pimagedine"],"crossReferences":{"PubChem":["11110767","11110768","11113705","124879244","50104571","50104572","90341334","90341800"],"Wikipedia":["Pimagedine"],"drugbank":["DB05383"],"chEBI":["40618"]},"childChemblIds":["CHEMBL1256292","CHEMBL1256617","CHEMBL1567020"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL233992","canonicalSmiles":"O=C(N[C@H]1CCC[C@H]1NC(=O)c1ccc(Cl)s1)c1ccc(-n2ccccc2=O)cc1","inchiKey":"QCPYHSAHOYXXQK-DLBZAZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233992","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2360841","canonicalSmiles":"CNC1=Nc2ccc(Cl)cc2C(c2ccc[nH]2)=NC1","inchiKey":"LEAKQIXYSHIHCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-24-7429","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO 24-7429","RO-24-7429","Ro 24-7429","Ro-24-7429"],"crossReferences":{"PubChem":["109967254"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2364635","canonicalSmiles":"COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1.O=C(O)CCC(=O)O","inchiKey":"CQBKFGJRAOXYIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFENOQUINE SUCCINATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL298470","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arakoda","Krintafel"],"synonyms":["SB-252263-AX","Tafenoquine succinate","WR-238605"],"crossReferences":{"DailyMed":["tafenoquine%20succinate"]},"count":1,"approvedIndications":["EFO_0007445"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for plasmodium vivax malaria."}
{"id":"CHEMBL259209","canonicalSmiles":"CCN(CC)C(=O)C1(c2ccccc2)CC1CN","inchiKey":"GJJFMKBJSRMPLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MILNACIPRAN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Midalcipran","Milnacipran"],"crossReferences":{"DailyMed":["milnacipran%20hydrochloride"],"drugbank":["DB04896"]},"childChemblIds":["CHEMBL4297064","CHEMBL3527085"],"count":5,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000685","EFO_0005687","EFO_0005296","EFO_0000555","EFO_0003757","HP_0003418","EFO_0003843","MONDO_0002050","EFO_0002506","HP_0030834","EFO_0003100","EFO_0005295","EFO_0003761","HP_0003419"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for unipolar depression and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL259223","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O","inchiKey":"DKHGMERMDICWDU-GHDNBGIDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENATETRENONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Menaquinone 4","Menatetrenone"],"crossReferences":{"PubChem":["11533054","144204118","144206963"],"drugbank":["DB12148"],"chEBI":["78277"]},"childChemblIds":["CHEMBL2024143","CHEMBL2024142"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL262101","canonicalSmiles":"c1ccc2c(c1)-c1nc-2nc2[nH]c(nc3nc(nc4[nH]c(n1)c1ccccc41)-c1ccccc1-3)c1ccccc21","inchiKey":"IEQIEDJGQAUEQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIAFTALAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciaftalan","Phthalocyanine"],"crossReferences":{"drugbank":["DB12983"],"chEBI":["34921"]},"childChemblIds":["CHEMBL2373172"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL26260","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12","inchiKey":"OUGIDAPQYNCXRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA-NAPHTHOFLAVONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5,6-Benzoflavone","Beta-Naphthoflavone"],"crossReferences":{"PubChem":["144212341","99356175"],"Wikipedia":["Beta-Naphthoflavone"],"drugbank":["DB06732"],"chEBI":["77013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262628","canonicalSmiles":"NNC(=O)c1[nH]c2ccc(S(N)(=O)=O)cc2c1-c1ccccc1","inchiKey":"PPDLAUCFAOODER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL262628","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08659"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267719","canonicalSmiles":"C=CCC1(CC=C)C(=O)NC(=O)NC1=O","inchiKey":"FDQGNLOWMMVRQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allobarbital","Diallylbarbituric acid","Diallymal"],"crossReferences":{"Wikipedia":["Allobarbital"],"drugbank":["DB13577"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL271475","canonicalSmiles":"O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I","inchiKey":"IPVFGAYTKQKGBM-BYPJNBLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIALURIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fialuridine","Fiau"],"crossReferences":{"Wikipedia":["Fialuridine"],"drugbank":["DB15427"]},"childChemblIds":["CHEMBL493085","CHEMBL213723"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL273822","canonicalSmiles":"CN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21","inchiKey":"PYXFWOIZPYXNRU-FSPLSTOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL273822","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275544","canonicalSmiles":"CCC(NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1","inchiKey":"BIAVGWDGIJKWRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL275544","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06429"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL290962","canonicalSmiles":"CCCN1C[C@@H](NS(=O)(=O)N(CC)CC)C[C@@H]2Cc3c(O)cccc3C[C@H]21","inchiKey":"GDFGTRDCCWFXTG-ZIFCJYIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINAGOLIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norprolac"],"crossReferences":{"Wikipedia":["Quinagolide"],"drugbank":["DB09097"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292280","canonicalSmiles":"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.Cl.[Cl-]","inchiKey":"GXFZCDMWGMFGFL-KKXMJGKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL292280","maximumClinicalTrialPhase":0,"parentId":"CHEMBL339427","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205592","170464882"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301742","canonicalSmiles":"NC[C@H](CC(=O)O)c1ccc(Cl)cc1","inchiKey":"KPYSYYIEGFHWSV-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARBACLOFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbaclofen","Baclofen (r)-form","STX-209","STX209"],"crossReferences":{"PubChem":["11113710"],"drugbank":["DB08891"]},"count":3,"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["HP_0001257","EFO_0003756","Orphanet_908"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL311350","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21","inchiKey":"RCIMBBZXSXFZBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIROMIDIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-93","Piromidic acid"],"crossReferences":{"PubChem":["11112653","144204138","170466042","26748599"],"drugbank":["DB13744"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL313842","canonicalSmiles":"COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F","inchiKey":"HJMQDJPMQIHLPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZARDAVERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zardaverine"],"crossReferences":{"PubChem":["11111981","11111982","11113879","144203858","170466644","26719752","26752043","26752044","49681610","50104699","50104700","85231289"],"drugbank":["DB02918"],"chEBI":["46548"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL313971","canonicalSmiles":"COc1cc(CNC(=O)CCCC/C=C\\C(C)C)ccc1O","inchiKey":"YKPUWZUDDOIDPM-VURMDHGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZUCAPSAICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zucapsaicin"],"crossReferences":{"PubChem":["11112338","11113255","11113512","11113513","124882262","124882263","26719735"],"drugbank":["DB09120"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL321113","canonicalSmiles":"O=C(O)Cc1ccc2c(c1O)C(=O)c1c(O)cccc1C2","inchiKey":"IXLRLZOYKJERRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL321113","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02019"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3247378","canonicalSmiles":"C[As](C)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O","inchiKey":"JGDXFQORBMPJGR-YUMQZZPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARINAPARSIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darinaparsin","ZIO-101"],"crossReferences":{"drugbank":["DB06179"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL326651","canonicalSmiles":"CCCCn1c(Cc2cc(OC)ccc2OC)nc2c(N)nc(F)nc21","inchiKey":"PASRTKOWXJDFFV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326651","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04054"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545055","drugType":"Small molecule","blackBoxWarning":false,"name":"INK-1117","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ink-1117"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545168","drugType":"Small molecule","blackBoxWarning":false,"name":"IMD-1041","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imd-1041"],"count":1,"linkedTargets":{"rows":["ENSG00000104365"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545271","drugType":"Small molecule","blackBoxWarning":false,"name":"PBF-999","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pbf-999"],"count":2,"linkedTargets":{"rows":["ENSG00000128271","ENSG00000112541"],"count":2},"linkedDiseases":{"rows":["Orphanet_399","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545287","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2624803","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DB-7","HY-10275","LY2624803","Ly2624803"],"count":1,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545365","canonicalSmiles":"O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1","inchiKey":"GNNDEPIMDAZHRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTIRATINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Altiratinib","DCC-2701","DP-5164"],"count":1,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000140538","ENSG00000120156","ENSG00000105976","ENSG00000148053","ENSG00000198400"],"count":6},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545374","drugType":"Antibody","blackBoxWarning":false,"name":"TREVOGRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-1033","REGN1033","SAR-391786","SAR391786","Trevogrumab"],"count":2,"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["EFO_1000653","EFO_0007323"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545414","canonicalSmiles":"CS(=O)(=O)O.N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1","inchiKey":"FYJROXRIVQPKRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVOCERANIB MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3186534","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aitan"],"synonyms":["Apatinib (registered name in China)","Apatinib mesylate","Rivoceranib mesylate","YN-968D1","Yn-968d1"],"count":53,"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003891","EFO_0000637","EFO_0000365","EFO_0000571","EFO_0000756","EFO_0000681","EFO_1001951","EFO_0000178","MONDO_0002974","MONDO_0008903","EFO_0000182","MONDO_0016784","EFO_0002618","EFO_0005922","EFO_0003893","EFO_1001956","MONDO_0002108","MONDO_0008170","EFO_0005842","EFO_1002017","EFO_0002939","EFO_1001968","EFO_0005221","EFO_0009708","MONDO_0015917","MONDO_0002691","EFO_0001061","MONDO_0000544","EFO_0005537","EFO_0004284","EFO_0000574","EFO_0002938","MONDO_0021117","MONDO_0007254","EFO_0001071","EFO_0000708","EFO_0004252","MONDO_0021063","EFO_0000231","MONDO_0001056","EFO_1001480","EFO_0003860","EFO_0000326","EFO_0000707","HP_0001541","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","EFO_0000503","EFO_0000403","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_0000311","EFO_1001961","EFO_0000211","EFO_0000702","EFO_0004142","MONDO_0003219","EFO_0000691","EFO_0000181"],"count":64},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 53 investigational indications."}
{"id":"CHEMBL359482","canonicalSmiles":"Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1","inchiKey":"JYCUVOXSZBECAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL359482","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08454"],"chEBI":["78544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL361403","canonicalSmiles":"C[C@](O)(CBr)CCOP(=O)(O)OP(=O)(O)O","inchiKey":"YKAYCWPQDPILSA-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL361403","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04170"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707257","canonicalSmiles":"O=[N+]([O-])OCCN(CCO[N+](=O)[O-])CCN(CCO[N+](=O)[O-])CCO[N+](=O)[O-]","inchiKey":"DLDKCSIJFIPYRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENITRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenitramine"],"crossReferences":{"drugbank":["DB13637"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707295","drugType":"Enzyme","blackBoxWarning":false,"name":"REVEGLUCOSIDASE ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMN 701","BMN-701","Reveglucosidase alfa","ZC-701"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707398","drugType":"Small molecule","blackBoxWarning":false,"name":"PAC-14028","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asivatrep","Pac-14028"],"count":4,"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_1000760","HP_0000989","EFO_1000764","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL371732","canonicalSmiles":"COc1cccc(-c2ccc(NC(=O)c3ccsc3C(=O)O)c(F)c2)c1","inchiKey":"GIUMGVUBDBDTDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL371732","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07976"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL375611","canonicalSmiles":"N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21","inchiKey":"AVDUGNCTZRCAHH-MDASVERJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY404039","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-404039","LY-404039, (-)-","LY404039","Ly404039"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL377300","canonicalSmiles":"Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1","inchiKey":"WCWUXEGQKLTGDX-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIVANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-540215","Brivanib"],"crossReferences":{"drugbank":["DB11958"]},"count":9,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000102755","ENSG00000037280","ENSG00000160867","ENSG00000077782"],"count":7},"linkedDiseases":{"rows":["EFO_1001951","EFO_0000616","MONDO_0002691","EFO_1001480","EFO_0000365","MONDO_0008170","EFO_0000182","EFO_0000313","EFO_0000311","EFO_0009708"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3781845","canonicalSmiles":"CO[P@@](=O)(c1cc(C)cc(/C=C/C#N)c1)c1c(C(N)=O)[nH]c2ccc(Cl)cc12","inchiKey":"CGBYTKOSZYQOPV-CCEZBSFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3781845","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06166"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL38434","canonicalSmiles":"Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O","inchiKey":"PHEZJEYUWHETKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BREQUINAR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brequinar"],"crossReferences":{"drugbank":["DB03523"]},"childChemblIds":["CHEMBL300058"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL38827","canonicalSmiles":"CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1","inchiKey":"DYLGFOYVTXJFJP-MYYYXRDXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMEFANTRINE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CPG-56695","GNF-PF-1971","Lumefantrine"],"crossReferences":{"DailyMed":["lumefantrine"],"PubChem":["124893326","144206044","170465388","50112743"],"Wikipedia":["Lumefantrine"],"drugbank":["DB06708"],"chEBI":["156095"]},"count":5,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for malaria and has 4 investigational indications."}
{"id":"CHEMBL3900554","canonicalSmiles":"Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O","inchiKey":"ZRYMMWAJAFUANM-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986142","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-986142"],"crossReferences":{"drugbank":["DB15291"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3916243","canonicalSmiles":"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)C=CSC(N)=N1","inchiKey":"VLLFGVHGKLDDLW-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATABECESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atabecestat","JNJ-54861911","JNJ-54861911-AAA","Jnj-54861911","RSC- 385896","RSC-385896"],"crossReferences":{"drugbank":["DB15307"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL398346","canonicalSmiles":"CCNC(=O)c1noc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1","inchiKey":"APGOABVITLQCKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL398346","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989715","canonicalSmiles":"C/C(=C\\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.C/C(=C\\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.O.O.[Ca+2]","inchiKey":"DDHVILIIHBIMQU-YJGQQKNPSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MUPIROCIN CALCIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL719","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bactroban","Mupirocin"],"synonyms":["BRL 4910F","BRL-4910F","Mupirocin calcium","Mupirocin calcium hydrate"],"crossReferences":{"DailyMed":["mupirocin%20calcium"]},"count":4,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for infection and has 3 investigational indications."}
{"id":"CHEMBL3989974","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O","inchiKey":"DBPPRLRVDVJOCL-FQRUVTKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFIDEROCOL","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefiderocol","GSK2696266","S-649266"],"crossReferences":{"DailyMed":["cefiderocol%20sulfate%20tosylate"],"drugbank":["DB14879"]},"childChemblIds":["CHEMBL4297211"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 4 investigational indications."}
{"id":"CHEMBL402747","canonicalSmiles":"CC#CCOc1ccc(S(=O)(=O)CCCS)cc1","inchiKey":"CARKQNSZFCLNKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL402747","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07079"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL407938","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O","inchiKey":"QCICUPZZLIQAPA-XPWFQUROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL407938","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01690"],"chEBI":["27775"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL416301","canonicalSmiles":"CCCCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"KKVZONPEMODBBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL416301","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07873"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL42423","canonicalSmiles":"O=[N+]([O-])c1ccc(O)c(O)c1","inchiKey":"XJNPNXSISMKQEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Nitrocatechol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Nitrocatechol"],"crossReferences":{"drugbank":["DB03407"],"chEBI":["16318"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425584","canonicalSmiles":"N[C@@H](CC(=O)N1CCC[C@H]1CNC(=O)c1ccccc1)Cc1ccccc1F","inchiKey":"ANQHSFFUNMTTRS-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425584","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07779"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL42743","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","inchiKey":"WBPYTXDJUQJLPQ-VMXQISHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYLOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tylan"],"synonyms":["E713","Tylosin"],"crossReferences":{"Wikipedia":["Tylosin"],"drugbank":["DB11475"],"chEBI":["17658"]},"childChemblIds":["CHEMBL1240892","CHEMBL3189100","CHEMBL1888653"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4296682","canonicalSmiles":"CCN(C)C(=O)c1ccc(-c2ccc3c(n2)Oc2ccccc2[C@@H]3C(C)(C)C(=O)Nc2nncs2)cc1F","inchiKey":"DZBKAUMYTFPJIS-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4296682","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15023"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297067","canonicalSmiles":"O=C1C=CC2C(=C1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21","inchiKey":"VDBJCDWTNCKRTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORESCEIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluorescite"],"synonyms":["CI 45350:1","Fluorescein","NSC-667256"],"crossReferences":{"DailyMed":["fluorescein%20sodium"]},"childChemblIds":["CHEMBL1628233"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 3 investigational indications."}
{"id":"CHEMBL4297188","canonicalSmiles":"Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1","inchiKey":"HNFMVVHMKGFCMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRANSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARQ 092","ARQ 092 FREE BASE","ARQ-092","Arq-092","Miransertib"],"crossReferences":{"drugbank":["DB14982"]},"childChemblIds":["CHEMBL4298151","CHEMBL4523032"],"count":4,"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["MONDO_0008170","MONDO_0011962","EFO_0000574","Orphanet_744"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297259","canonicalSmiles":"CC1(C)CN[Se]c2ccccc21","inchiKey":"FXRYWOJYVGJZLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALT-2074","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alt-2074","BXT-51072","Bxt-51072","SYI 2074","SYI-2074"],"crossReferences":{"drugbank":["DB05631"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297291","canonicalSmiles":"O=C(O)CCCC(=O)NCCc1c[nH]cn1","inchiKey":"KZIMLUFVKJLCCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INGAVIRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidazolyl ethanamide pentandioic acid","Ingavirin"],"crossReferences":{"drugbank":["DB11944"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297360","canonicalSmiles":"CCCCOP(=O)(O)OC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1OP(=O)(O)OCCCC","inchiKey":"ZXQBUNYVGNOEBQ-ARFHVFGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-3","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bisphosphocin nu-3","Nu-3"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297365","canonicalSmiles":"[131Cs]","inchiKey":"TVFDJXOCXUVLDH-YPZZEJLDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CESIUM CS-131","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4302507","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cesium cs-131","Cesium-131"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297433","canonicalSmiles":"CS(=O)(=O)F","inchiKey":"KNWQLFOXPQZGPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHANESULFONYL FLUORIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methanesulfonyl fluoride","SNX-001","Snx-001"],"crossReferences":{"drugbank":["DB13058"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297469","canonicalSmiles":"Cc1cc(C)c(-c2ccc(NC(=O)[C@H](Cc3ccc(C(=O)NCCS(=O)(=O)O)cc3)c3ccc(-c4ccc(C(C)(C)C)cc4)cc3)cc2)c(C)c1","inchiKey":"HKJMCBYPVCGZFB-LDLOPFEMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LGD-6972","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGD-6972","Lgd-6972","MB-11262"],"crossReferences":{"drugbank":["DB14779"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297476","canonicalSmiles":"C[C@@H]1CNS(=O)(=O)N(c2ccc3c(C#N)nccc3c2)C1","inchiKey":"ZKAVFOXYJCREBQ-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06260414","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06260414","Pf-06260414"],"crossReferences":{"drugbank":["DB15221"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297661","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1","inchiKey":"MUJMYVFVAWFUJL-SNAWJCMRSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"TARLOXOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tarloxotinib"],"crossReferences":{"drugbank":["DB14944"]},"childChemblIds":["CHEMBL4297662"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297714","drugType":"Unknown","blackBoxWarning":false,"name":"CALMANGAFODIPIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calmangafodipir","PP100-01"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297751","drugType":"Unknown","blackBoxWarning":false,"name":"FERMAGATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fermagate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297769","drugType":"Unknown","blackBoxWarning":false,"name":"IMCNYESO","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMCNYESO","Imcnyeso"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297866","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1.O.O.O=C(O)/C=C\\C(=O)O","inchiKey":"QITOONQVTOGMOJ-IUJXYRIYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABIVERTINIB MALEATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4297865","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-610MA","A610MA","AC-0010MA","AC0010MA","ACEA-100610MA","ACEA100610MA","Abivertinib maleate","Ac0010ma","EX-ACEA-0010MA","EX-ACEA0010MA"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297884","drugType":"Antibody","blackBoxWarning":false,"name":"PEPINEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-sema4d monoclonal antibody vx15/2503","Pepinemab","VX-15","VX-152503","VX15","VX15/2503","Vx15/2503"],"count":7,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4298121","drugType":"Unknown","blackBoxWarning":false,"name":"KALLIKREIN-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kallikrein-1","Tissue kallikrein"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298213","drugType":"Antibody","blackBoxWarning":false,"name":"VOLAGIDEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 477","AMG-477","REMD-477","Volagidemab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL438303","canonicalSmiles":"N#Cc1cnn2c(Nc3ccccc3)nc(NCC3CCCCC3)nc12","inchiKey":"NCVMTHVSAJMOPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL438303","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08353"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL449","canonicalSmiles":"CCC(C)C1(CC)C(=O)NC(=O)NC1=O","inchiKey":"ZRIHAIZYIMGOAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTABARBITAL","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butabarbital","Secbutabarbital","Secbutobarbitone"],"crossReferences":{"Wikipedia":["Butabarbital"],"drugbank":["DB00237"],"chEBI":["3228"]},"childChemblIds":["CHEMBL1200982"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939."}
{"id":"CHEMBL450","canonicalSmiles":"CCC1(CC)C(=O)NC(=O)N(C)C1=O","inchiKey":"FWJKNZONDWOGMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHARBITAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gemonil"],"synonyms":["Endiemal","Metharbital"],"crossReferences":{"PubChem":["144206305"],"Wikipedia":["Metharbital"],"drugbank":["DB00463"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for epilepsy."}
{"id":"CHEMBL453620","canonicalSmiles":"C[C@](O)(c1ccc(C(=O)N(C2CC2)C2CCN(CC3(C(N)=O)CC3)CC2)cc1)C(F)(F)F","inchiKey":"FAVXIEFZKPJZRT-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL453620","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL454568","canonicalSmiles":"CO/C(=C/C(N)=O)[C@H](C)[C@H](/C=C/c1csc(-c2csc([C@@H](C)/C=C/C=C/C(C)C)n2)n1)OC","inchiKey":"XKTFQMCPGMTBMD-FYHMSGCOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MYXOTHIAZOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Myxothiazol"],"crossReferences":{"drugbank":["DB04741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457665","canonicalSmiles":"N[C@@H](CSS(=O)(=O)O)C(=O)O","inchiKey":"NOKPBJYHPHHWAN-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL457665","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113387","26756632","26756633"],"drugbank":["DB04370"],"chEBI":["27891"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594366","drugType":"Unknown","blackBoxWarning":false,"name":"IGN-002","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IGN-002","IGN002","Ign-002","Ign002"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594442","canonicalSmiles":"Cc1cc(-c2nnc(N)nc2-c2ccc(F)cc2)cc(Cl)n1","inchiKey":"NCWQLHHDGDXIJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMARADENANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4635","AZD4635","Azd 4635","Azd4635","HTL-1071","HTL1071","Imaradenant"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594533","drugType":"Unknown","blackBoxWarning":false,"name":"CBX-129801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CBX-129801","CBX129801","Cbx-129801","Cbx129801"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL464","canonicalSmiles":"CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C","inchiKey":"HQMNCQVAMBCHCO-DJRRULDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRETINATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," United States"],"classes":["Teratogenicity"],"year":1989},"tradeNames":["Tegison","Tigason"],"synonyms":["Etretinate","RO 10-9359","Ro-109359"],"crossReferences":{"PubChem":["144206054","170465372","50112753"],"Wikipedia":["Etretinate"],"chEBI":["4913"]},"count":1,"approvedIndications":["EFO_0000676"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819","ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":6},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for psoriasis. It was withdrawn in France and  United States initially in 1989 due to Teratogenicity."}
{"id":"CHEMBL466246","canonicalSmiles":"CO[C@H]([C@H](O)CO)[C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O","inchiKey":"QNRRHYPPQFELSF-CNYIRLTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANINAMIVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-125489"],"crossReferences":{"Wikipedia":["Laninamivir"],"drugbank":["DB12791"]},"childChemblIds":["CHEMBL1673194","CHEMBL436160"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL467987","canonicalSmiles":"C[C@]12CC[C@@H]3c4cc(O)c(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"DILDHNKDVHLEQB-XSSYPUMDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Hydroxy-Estradiol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Hydroxy-Estradiol","2-Hydroxyestradiol"],"crossReferences":{"PubChem":["11532926"],"drugbank":["DB07706"],"chEBI":["28744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL470617","canonicalSmiles":"C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.[I-]","inchiKey":"VYZRRRRJXDLIFG-KNLJMPJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALTREXONE METHIODIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1186579","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naltrexone Methiodide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL475398","canonicalSmiles":"Oc1ccc(-c2ccccc2)cc1O","inchiKey":"QDNPCYCBQFHNJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Phenylcatechol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Phenylcatechol"],"crossReferences":{"drugbank":["DB07478"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL486954","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"XMRPGKVKISIQBV-XWOJZHJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL486954","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07557"],"chEBI":["30154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL507282","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)O2)c(=O)n1","inchiKey":"FPNPSEMJLALQSA-MIYUEGBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DENUFOSOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denufosol"],"crossReferences":{"drugbank":["DB04983"]},"childChemblIds":["CHEMBL1767407"],"linkedTargets":{"rows":["ENSG00000175591"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","Orphanet_586","EFO_0005773","EFO_1001417"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL514201","canonicalSmiles":"C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1","inchiKey":"ZMELOYOKMZBMRB-DLBZAZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCIO 469","SCIO-469","Scio-469","Talmapimod"],"crossReferences":{"drugbank":["DB05412"],"chEBI":["90683"]},"count":2,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0001378"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL541388","canonicalSmiles":"Cl.O=S(=O)(c1cccc2cnccc12)N1CCCNCC1","inchiKey":"LFVPBERIVUNMGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASUDIL HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL38380","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasudil","Fasudil hydrochloride"],"crossReferences":{"PubChem":["144204375","170466011","855669"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL560403","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)n1","inchiKey":"RGWHQCVHVJXOKC-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYCYTIDINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxycytidine 5'-Triphosphate","Deoxycytidine Triphosphate"],"crossReferences":{"drugbank":["DB03258"],"chEBI":["16311"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL582857","canonicalSmiles":"COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccccc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1","inchiKey":"NJXZWIIMWNEOGJ-WEWKHQNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NELIVAPTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nelivaptan","SR-149415","SSR-149,415","SSR-149415","SSR149415","Ssr149415"],"crossReferences":{"PubChem":["144210560"],"Wikipedia":["Nelivaptan"],"drugbank":["DB12643"]},"childChemblIds":["CHEMBL1098000"],"count":2,"linkedTargets":{"rows":["ENSG00000198049"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0005230"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL603367","canonicalSmiles":"O=P(O)(O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"YXJDFQJKERBOBM-TXICZTDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL603367","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03101"],"chEBI":["16300"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL63130","canonicalSmiles":"N[C@@H](CSCc1ccccc1)C(=O)O","inchiKey":"GHBAYRBVXCRIHT-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYLCYSTEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4252966"],"drugbank":["DB04531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL649","canonicalSmiles":"CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2","inchiKey":"VWPOSFSPZNDTMJ-UCWKZMIHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NADOLOL","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corgard","Nadolol","Solgol"],"synonyms":["Nadolol","SQ 11725","SQ-11725"],"crossReferences":{"DailyMed":["nadolol"],"PubChem":["144204197","170464945","56422422","855594"],"Wikipedia":["Nadolol"],"drugbank":["DB01203"]},"count":5,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","MP_0001914","EFO_0003821","EFO_0000270","EFO_0000319","EFO_1000635","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for hypertension and cardiovascular disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL6640","canonicalSmiles":"NCCc1c[nH]c2ccccc12","inchiKey":"APJYDQYYACXCRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRYPTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110664","124879002","14719299","90340989"],"Wikipedia":["Tryptamine"],"drugbank":["DB08653"],"chEBI":["16765"]},"childChemblIds":["CHEMBL1255796"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL702","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O","inchiKey":"IVBHGBMCVLDMKU-GXNBUGAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERACILLIN","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Piperacillin","Piperacillin hydrate"],"crossReferences":{"DailyMed":["piperacillin%20sodium"],"Wikipedia":["Piperacillin"],"drugbank":["DB00319"],"chEBI":["8232"]},"childChemblIds":["CHEMBL1200820"],"count":19,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for bacterial disease and has 18 investigational indications."}
{"id":"CHEMBL71752","canonicalSmiles":"CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32","inchiKey":"DDNCQMVWWZOMLN-IRLDBZIGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINPOCETINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cavinton"],"synonyms":["AY-27,255","AY-27255","Vinpocetine"],"crossReferences":{"PubChem":["104171371","144204199","144204390","170465859","50103960","50103961","56424092","85231349","855619","90341018"],"Wikipedia":["Vinpocetine"],"drugbank":["DB12131"]},"count":2,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for attention deficit hyperactivity disorder and has 1 investigational indication."}
{"id":"CHEMBL728","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"WIKYUJGCLQQFNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCHLORPERAZINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Compazine","Compro","Prochlorperazine","Stemetil eff"],"synonyms":["Prochlorperazine","Prochlorperazine mesilate"],"crossReferences":{"DailyMed":["prochlorperazine","prochlorperazine%20edisylate","prochlorperazine%20maleate"],"PubChem":["11111685","11111686","50100332","50104093","855827","90341442"],"Wikipedia":["Prochlorperazine"],"drugbank":["DB00433"],"chEBI":["8435"]},"childChemblIds":["CHEMBL1200587","CHEMBL1201154","CHEMBL1314751"],"count":7,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0001416","EFO_1001482","EFO_0006911","EFO_0003821","HP_0002017","EFO_0004888","EFO_0005407","HP_0002315","HP_0002018"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and is indicated for psychosis and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL752","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"UDMBCSSLTHHNCD-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADENOSINE PHOSPHATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Adenyl","My-b-den"],"synonyms":["5'-adenylic acid","A 5MP","A-5MP","Adenosine Monophosphate","Adenosine phosphate","NSC-20264","Vitamin b8"],"crossReferences":{"PubChem":["144205599","170466132","26756674"],"Wikipedia":["Adenosine_monophosphate"],"drugbank":["DB00131"],"chEBI":["16027"]},"childChemblIds":["CHEMBL1627080","CHEMBL1315633"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL771","canonicalSmiles":"N[C@@H]1CONC1=O","inchiKey":"DYDCUQKUCUHJBH-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOSERINE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Seromycin"],"synonyms":["Cycloserine","NSC-154851","NSC-76029"],"crossReferences":{"DailyMed":["cycloserine"],"PubChem":["11110913","11110914","11110915","11112194","11112195","144203912","170465249","26719637","50106003","85231334","90341765"],"Wikipedia":["Cycloserine"],"drugbank":["DB00260"],"chEBI":["40009"]},"childChemblIds":["CHEMBL1222336"],"count":28,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for tuberculosis and has 27 investigational indications."}
{"id":"CHEMBL782","canonicalSmiles":"CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1","inchiKey":"JLRGJRBPOGGCBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLBUTAMIDE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glyconon","Orinase","Pramidex","Rastinon","Tolbutamide"],"synonyms":["NSC-23813","NSC-87833","Tolbutamide"],"crossReferences":{"DailyMed":["tolbutamide"],"PubChem":["11111858","144203830","144208810","144213112","170465238","17389707","26751511","26751513","50104069","56436662","855782"],"TG-GATEs":["114"],"Wikipedia":["Tolbutamide"],"drugbank":["DB01124"],"chEBI":["27999"]},"childChemblIds":["CHEMBL1200874"],"count":6,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004220","HP_0012532","EFO_0000574","EFO_0001360","EFO_0000400"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 4 investigational indications."}
{"id":"CHEMBL818","canonicalSmiles":"N=C(N)NCc1cccc(I)c1","inchiKey":"PDWUPXJEEYOOTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENGUANE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iobenguane"],"crossReferences":{"DailyMed":["iobenguane%20i-131","iobenguane%20sulfate%20i-123"],"PubChem":["11111341","90341658"],"Wikipedia":["Iobenguane"],"drugbank":["DB06704"]},"childChemblIds":["CHEMBL1374843","CHEMBL1615777","CHEMBL3989511","CHEMBL4584538","CHEMBL1615779","CHEMBL3989523","CHEMBL1255738"],"count":3,"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_1001901","MONDO_0024503","EFO_0003144","EFO_1000453","EFO_0000621","EFO_0000239"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 3 investigational indications."}
{"id":"CHEMBL82301","canonicalSmiles":"COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C","inchiKey":"CNPVJJQCETWNEU-CYFREDJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VICRIVIROC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-7690","SCH-351125","SCH-417690 FREE BASE","SCH-D","Vicriviroc"],"crossReferences":{"Wikipedia":["Vicriviroc"],"drugbank":["DB06652"]},"childChemblIds":["CHEMBL2107384"],"count":3,"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000765","EFO_0000764","EFO_0004142"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL832","canonicalSmiles":"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1","inchiKey":"MBGGBVCUIVRRBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFINPYRAZONE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anturan","Anturane","Sulfinpyrazone"],"synonyms":["Sulfinpyrazone","Sulphinpyrazone"],"crossReferences":{"PubChem":["11112139","124881954","144203882","170464677","26747070","46500625","855982"],"Wikipedia":["Sulfinpyrazone"],"drugbank":["DB01138"],"chEBI":["9342"]},"count":1,"approvedIndications":["EFO_0004274"],"linkedTargets":{"rows":["ENSG00000197891"],"count":1},"linkedDiseases":{"rows":["EFO_0004274"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for gout."}
{"id":"CHEMBL94277","canonicalSmiles":"COC1=CC(=O)c2c(c(COc3ccccc3)c(C)n2C)C1=O","inchiKey":"JRPJCFILHCLEJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL94277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03626"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL957","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO","inchiKey":"GJPICJJJRGTNOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BOSENTAN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tracleer"],"synonyms":["Bosentan","Bosentan hydrate","Bosentan monohydrate","RO 47-0203/029","RO-47-0203-029","RO-470203029"],"crossReferences":{"DailyMed":["bosentan"],"PubChem":["144205997","170465245"],"Wikipedia":["Bosentan"],"drugbank":["DB00559"],"chEBI":["51450"]},"childChemblIds":["CHEMBL175616"],"count":24,"approvedIndications":["Orphanet_422","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["EFO_0007372","EFO_0002618","MONDO_0005149","EFO_0001361","EFO_1001346","EFO_1001103","EFO_0000756","EFO_0000768","EFO_1000809","EFO_0009200","EFO_0005207","Orphanet_422","HP_0001945","EFO_0000373","MONDO_0043839","MONDO_0004933","EFO_0000537","EFO_0001422","EFO_0000270","Orphanet_1478","EFO_0000341","EFO_0000516","EFO_0001360","EFO_0000717","EFO_0000400"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for idiopathic and/or familial pulmonary arterial hypertension and hypertension and has 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL981","canonicalSmiles":"CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O","inchiKey":"MQOBSOSZFYZQOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOFIBRIC ACID","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fenocor-67","Fenogal","Fibricor","Lipanthyl","Lipofen","Lofibra","Supralip","Trilipix"],"synonyms":["Fenofibrate free acid","Fenofibrate related compound b","Fenofibric acid","LF-153","NSC-281318"],"crossReferences":{"DailyMed":["choline%20fenofibrate","fenofibric%20acid"],"drugbank":["DB13873"],"chEBI":["83469"]},"childChemblIds":["CHEMBL1201745"],"count":4,"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","HP_0003124","MONDO_0001751","EFO_0001645","Orphanet_79211","EFO_0002939","EFO_0000319","EFO_0009321","Orphanet_309005","EFO_0003829"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 investigational indications."}
